TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 95 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $7,000 | -66.7% | 15,613 | 0.0% | 0.00% | – |
Q1 2019 | $21,000 | +16.7% | 15,613 | 0.0% | 0.00% | – |
Q4 2018 | $18,000 | -58.1% | 15,613 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $43,000 | -97.6% | 15,613 | -96.8% | 0.00% | -96.4% |
Q2 2018 | $1,769,000 | +10.7% | 495,613 | -4.8% | 0.03% | +3.7% |
Q1 2018 | $1,598,000 | -49.8% | 520,613 | +3.1% | 0.03% | -50.9% |
Q4 2017 | $3,182,000 | +18.4% | 505,000 | +28.5% | 0.06% | +17.0% |
Q3 2017 | $2,688,000 | +87.6% | 393,000 | +95.5% | 0.05% | +74.1% |
Q2 2017 | $1,433,000 | -22.4% | 201,000 | 0.0% | 0.03% | -25.0% |
Q1 2017 | $1,847,000 | +22.6% | 201,000 | -46.3% | 0.04% | +2.9% |
Q4 2016 | $1,507,000 | +5.2% | 374,000 | 0.0% | 0.04% | +2.9% |
Q3 2016 | $1,432,000 | -10.9% | 374,000 | 0.0% | 0.03% | -19.0% |
Q2 2016 | $1,608,000 | +22.9% | 374,000 | +31.7% | 0.04% | +27.3% |
Q1 2016 | $1,308,000 | -38.9% | 284,000 | +33.0% | 0.03% | -42.1% |
Q4 2015 | $2,142,000 | +164.4% | 213,600 | +96.7% | 0.06% | +185.0% |
Q3 2015 | $810,000 | -88.1% | 108,600 | -24.1% | 0.02% | -85.8% |
Q2 2015 | $6,784,000 | +50.5% | 143,000 | +16.3% | 0.14% | +54.9% |
Q1 2015 | $4,508,000 | +106.4% | 123,000 | +123.6% | 0.09% | +97.8% |
Q4 2014 | $2,184,000 | – | 55,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |